Survival interleukin 3. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy30

Cells, Cultured T-Lymphocytes Cell Line Cell Line, Tumor Tumor Cells, Cultured Macrophages Spleen Monocytes CD4-Positive T-Lymphocytes B-Lymphocytes Th2 Cells Killer Cells, Natural Leukocytes, Mononuclear Th1 Cells Lymphocytes Dendritic Cells Lung Bone Marrow Cells Lymph Nodes T-Lymphocytes, Helper-Inducer Fibroblasts CD8-Positive T-Lymphocytes Hematopoietic Stem Cells Neutrophils Killer Cells, Lymphokine-Activated T-Lymphocyte Subsets Epithelial Cells Bone Marrow Eosinophils Liver

Organisms10

Mice, Inbred C57BL Mice, Inbred BALB C Mice, Knockout Mice, Transgenic Mice, Inbred C3H Mice, Inbred Strains Mice, Nude Mice, SCID Rats, Sprague-Dawley Mice, Inbred DBA

Diseases34

Lung Neoplasms Inflammation Disease Models, Animal Breast Neoplasms Neoplasm Recurrence, Local Adenocarcinoma Neoplasm Metastasis Disease Progression Melanoma Liver Neoplasms Brain Neoplasms Neoplasms Lymphatic Metastasis Carcinoma, Squamous Cell Recurrence Colorectal Neoplasms Kidney Neoplasms Carcinoma, Non-Small-Cell Lung Ovarian Neoplasms Carcinoma, Renal Cell Carcinoma, Hepatocellular Glioblastoma Multiple Myeloma Pancreatic Neoplasms Neoplasm Invasiveness Carcinoma Acute Disease Stomach Neoplasms Prostatic Neoplasms Colonic Neoplasms Glioma Sepsis Postoperative Complications Bone Neoplasms

Chemicals and Drugs88

Interleukin-1 Interleukin-2 Interleukin-6 Receptors, Interleukin Cytokines Interleukin-4 Interleukin-10 Tumor Necrosis Factor-alpha Interleukins Interleukin-8 RNA, Messenger Interleukin 1 Receptor Antagonist Protein Interferon-gamma Recombinant Proteins Receptors, Interleukin-2 Interleukin-12 Interleukin-3 Receptors, Interleukin-1 Interleukin-1beta Interleukin-5 Antibodies, Monoclonal Antineoplastic Agents Lipopolysaccharides Interleukin-18 Antigens, CD NF-kappa B Receptors, Interleukin-4 Tumor Markers, Biological Interleukin-13 Receptors, Interleukin-6 Interleukin-11 Receptors, Immunologic Interleukin-15 Interleukin-7 Interleukin-17 STAT3 Transcription Factor Proto-Oncogene Proteins Cisplatin Inflammation Mediators DNA-Binding Proteins Biological Markers Lymphokines Cyclophosphamide Fluorouracil Doxorubicin Membrane Glycoproteins Interleukin-13 Receptor alpha1 Subunit Growth Substances Receptors, Interleukin-13 Sialoglycoproteins Immunosuppressive Agents Antigens, Differentiation, T-Lymphocyte Survival of Motor Neuron 1 Protein DNA Primers Transcription Factors Antigens, CD3 Phosphatidylinositol 3-Kinases Enzyme Inhibitors Dexamethasone Neoplasm Proteins Receptors, Interleukin-7 Vincristine RNA, Small Interfering Antibodies Membrane Proteins Protein-Serine-Threonine Kinases Cytokine Receptor gp130 Receptors, Antigen, T-Cell Protein-Tyrosine Kinases Recombinant Fusion Proteins DNA Trans-Activators Caspase 1 Phytohemagglutinins Interleukin-1alpha Dinoprostone Interleukin-23 Etoposide Receptors, Interleukin-1 Type I Receptors, Interleukin-5 Chemokines STAT6 Transcription Factor Anti-Inflammatory Agents Immunoglobulin E Prednisone Adjuvants, Immunologic Mitogen-Activated Protein Kinases Antigens, Surface

Analytical, Diagnostic and Therapeutic Techniques and Equipment53

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Neoplasm Staging Follow-Up Studies Proportional Hazards Models Antineoplastic Combined Chemotherapy Protocols Lymphocyte Activation Combined Modality Therapy Prognosis Immunohistochemistry Reverse Transcriptase Polymerase Chain Reaction Disease Models, Animal Multivariate Analysis Enzyme-Linked Immunosorbent Assay Prospective Studies Risk Factors Cohort Studies Transfection Blotting, Western Flow Cytometry Transplantation, Homologous Chemotherapy, Adjuvant Predictive Value of Tests Immunotherapy Polymerase Chain Reaction Drug Administration Schedule Registries Gene Expression Profiling Analysis of Variance Case-Control Studies Risk Assessment Neoplasm Transplantation Kidney Transplantation Remission Induction Actuarial Analysis Liver Transplantation Models, Biological Statistics, Nonparametric Coculture Techniques Radiotherapy, Adjuvant Leukocyte Count Life Tables Immunophenotyping Cell Count Severity of Illness Index Heart Transplantation SEER Program Immunoenzyme Techniques Oligonucleotide Array Sequence Analysis

Phenomena and Processes38

Cell Survival Graft Survival Time Factors Signal Transduction Apoptosis Lymphocyte Activation Cell Division Gene Expression Regulation Gene Expression Dose-Response Relationship, Drug Cell Proliferation Cell Differentiation Base Sequence Up-Regulation Transfection Phosphorylation Gene Expression Regulation, Neoplastic Mutation Phenotype Graft Rejection Down-Regulation Cytotoxicity, Immunologic Transcription, Genetic Drug Synergism Enzyme Activation Cell Death Amino Acid Sequence Promoter Regions, Genetic Kinetics Cell Movement Leukocyte Count Genotype Immunity, Innate Microbial Viability Cell Count Tissue Survival Immunity, Cellular Immune Tolerance

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Information Science7

Survival Rate Molecular Sequence Data Base Sequence Registries Amino Acid Sequence Life Tables SEER Program

Health Care23

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Follow-Up Studies Proportional Hazards Models Multivariate Analysis Prospective Studies Risk Factors Cohort Studies Age Factors Predictive Value of Tests Registries Analysis of Variance Case-Control Studies Risk Assessment Actuarial Analysis Statistics, Nonparametric Life Tables Severity of Illness Index SEER Program

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care

Survival Rate Cell Survival Disease-Free Survival Survival Survival Analysis Graft Survival Interleukin-1 Interleukin-2 Interleukin-6 Receptors, Interleukin Cytokines Treatment Outcome Cells, Cultured Time Factors Interleukin-4 Mice, Inbred C57BL Interleukin-10 Tumor Necrosis Factor-alpha Interleukins Kaplan-Meier Estimate Interleukin-8 RNA, Messenger Retrospective Studies T-Lymphocytes Signal Transduction Interleukin 1 Receptor Antagonist Protein Apoptosis Interferon-gamma Recombinant Proteins Receptors, Interleukin-2 Mice, Inbred BALB C Neoplasm Staging Follow-Up Studies Proportional Hazards Models Interleukin-12 Cell Line Interleukin-3 Antineoplastic Combined Chemotherapy Protocols Lymphocyte Activation Receptors, Interleukin-1 Combined Modality Therapy Interleukin-1beta Prognosis Cell Division Immunohistochemistry Lung Neoplasms Interleukin-5 Mice, Knockout Antibodies, Monoclonal Reverse Transcriptase Polymerase Chain Reaction Gene Expression Regulation Inflammation Cell Line, Tumor Antineoplastic Agents Tumor Cells, Cultured Lipopolysaccharides Disease Models, Animal Interleukin-18 Gene Expression Molecular Sequence Data Dose-Response Relationship, Drug Macrophages Cell Proliferation Multivariate Analysis Cell Differentiation Breast Neoplasms Neoplasm Recurrence, Local Antigens, CD Spleen Enzyme-Linked Immunosorbent Assay NF-kappa B Receptors, Interleukin-4 Adenocarcinoma Neoplasm Metastasis Tumor Markers, Biological Interleukin-13 Receptors, Interleukin-6 Prospective Studies Monocytes Base Sequence CD4-Positive T-Lymphocytes Disease Progression Up-Regulation Risk Factors Melanoma Interleukin-11 Receptors, Immunologic B-Lymphocytes Cohort Studies Interleukin-15 Mice, Transgenic Interleukin-7 Liver Neoplasms Th2 Cells Transfection Phosphorylation Blotting, Western Killer Cells, Natural Interleukin-17 Brain Neoplasms

No FAQ available that match "survival interleukin 3"